Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
26
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.08B | 0.99% |
5,951,963
+711,725
| +14% | +$123M |
|
27
Under Armour
UAA
$3.01B
| $1.06B | 0.98% |
25,702,980
+2,259,543
| +10% | +$90.8M |
|
28
Abbott
ABT
$188B
| $1.03B | 0.95% |
21,072,558
-498,635
| -2% | -$23.9M |
|
|
CXO
29
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.03B | 0.95% |
9,076,034
-745,008
| -8% | -$90.3M |
|
30
Costco
COST
$432B
| $992M | 0.91% |
7,346,732
-994,204
| -12% | -$143M |
|
31
Marriott International
MAR
$100B
| $983M | 0.9% |
13,219,223
+828,787
| +7% | +$65.5M |
|
32
Morgan Stanley
MS
$319B
| $931M | 0.85% |
23,995,075
-463,024
| -2% | -$17.6M |
|
|
MON
33
DELISTED
Monsanto Co
MON
| $900M | 0.83% |
8,446,921
-1,062,326
| -11% | -$123M |
|
34
Corpay
CPAY
$25.7B
| $889M | 0.81% |
5,694,787
+71,350
| +1% | +$11.2M |
|
|
35
Regeneron Pharmaceuticals
REGN
$72.9B
| $884M | 0.81% |
+1,732,726
| New | +$846M |
|
|
36
JD.com
JD
$43.5B
| $845M | 0.77% |
24,766,423
+22,998,175
| +1,301% | +$782M |
|
|
SPLK
37
DELISTED
Splunk Inc
SPLK
| $843M | 0.77% |
12,101,849
-316,903
| -3% | -$21.3M |
|
38
O'Reilly Automotive
ORLY
$75.1B
| $840M | 0.77% |
55,754,475
-2,317,230
| -4% | -$34.4M |
|
|
39
Alibaba
BABA
$276B
| $795M | 0.73% |
9,664,836
-5,320,050
| -36% | -$457M |
|
40
BioMarin Pharmaceuticals
BMRN
$11.9B
| $752M | 0.69% |
5,498,822
+97,848
| +2% | +$12.1M |
|
41
SLB Ltd
SLB
$72.7B
| $743M | 0.68% |
8,624,957
-698,441
| -7% | -$63M |
|
42
American Tower
AMT
$83.5B
| $734M | 0.67% |
7,869,966
-212,024
| -3% | -$20.1M |
|
|
TWX
43
DELISTED
Time Warner Inc
TWX
| $730M | 0.67% |
8,348,746
+522,737
| +7% | +$44.6M |
|
44
Workday
WDAY
$41.5B
| $695M | 0.64% |
9,097,885
+710,645
| +8% | +$60.5M |
|
45
EOG Resources
EOG
$77.7B
| $667M | 0.61% |
7,619,257
-247,189
| -3% | -$22.8M |
|
|
46
Dollar General
DG
$28.4B
| $667M | 0.61% |
+8,573,502
| New | +$647M |
|
|
47
NXP Semiconductors
NXPI
$60.8B
| $638M | 0.58% |
6,494,787
+2,342,810
| +56% | +$240M |
|
|
ARMH
48
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $633M | 0.58% |
12,846,045
-2,933,068
| -19% | -$153M |
|
49
Vertex Pharmaceuticals
VRTX
$123B
| $630M | 0.58% |
5,105,254
-1,443,237
| -22% | -$182M |
|
50
TJX Companies
TJX
$179B
| $603M | 0.55% |
18,214,870
-701,406
| -4% | -$23.3M |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.